Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Gensight Biologics has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This action is being reviewed by 1 distinct examiner, OKONAK, ELIZABETH LOUISE. The prosecution is currently confined to 1 distinct art unit. This organizational structure suggests a highly focused prosecution strategy in this specific technological field, as the company is not currently navigating multiple art units or examiner perspectives.
As the busiest examiner for the company, OKONAK, ELIZABETH LOUISE is responsible for 1 pending office action. This single matter represents the company's total active docket. The use of 1 distinct examiner for 1 pending office action within 1 distinct art unit indicates a highly focused and singular prosecution effort in the medical device field. For a practitioner, this means that the company's current success in the Medical Devices & Mechanical Engineering sector depends on the outcomes of this singular interaction, emphasizing the importance of this specific examiner relationship.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OKONAK, ELIZABETH LOUISE | 1 | 16.7% | +83.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18623256 | METHOD FOR CONTROLLING AN OPTOGENETIC DEVICE USING FILTERING AND ASSOCIATED DEVICES | OKONAK, ELIZABETH LOUISE | 35d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18623256 | METHOD FOR CONTROLLING AN OPTOGENETIC DEVICE USING FILTERING AND ASSOCIATED DEVICES | OKONAK, ELIZABETH LOUISE | 35d overdue |
| Art Unit | Apps |
|---|---|
| 3792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18623256 | METHOD FOR CONTROLLING AN OPTOGENETIC DEVICE USING FILTERING AND ASSOCIATED DEVICES | OKONAK, ELIZABETH LOUISE | 3792 | §103§112DP | Final Rejection | 35d overdue | Pending | Apr 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial